Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (161) 161
index medicus (154) 154
female (147) 147
middle aged (100) 100
oncology (94) 94
breast cancer (89) 89
breast neoplasms - genetics (89) 89
aged (78) 78
adult (75) 75
risk factors (67) 67
case-control studies (57) 57
genetic predisposition to disease (53) 53
genotype (48) 48
polymorphism, single nucleotide (46) 46
research (45) 45
risk (45) 45
breast neoplasms - pathology (42) 42
genetic aspects (42) 42
prognosis (39) 39
genome-wide association (38) 38
cancer (34) 34
genetics & heredity (31) 31
survival (30) 30
breast neoplasms - mortality (29) 29
male (29) 29
genetics (28) 28
odds ratio (28) 28
alleles (27) 27
women (27) 27
medicin och hälsovetenskap (25) 25
aged, 80 and over (24) 24
medical and health sciences (24) 24
article (23) 23
medicine (23) 23
research article (22) 22
health aspects (21) 21
genome-wide association study (20) 20
medical research (20) 20
breast neoplasms - metabolism (19) 19
confer susceptibility (19) 19
finland (19) 19
treatment outcome (19) 19
breast neoplasms - diagnosis (18) 18
common variants (18) 18
finland - epidemiology (18) 18
follow-up studies (18) 18
polymorphism, single nucleotide - genetics (18) 18
survival analysis (18) 18
estrogen (17) 17
tumors (17) 17
chemotherapy (16) 16
expression (16) 16
prospective studies (16) 16
cancer och onkologi (15) 15
care and treatment (15) 15
earth drilling (15) 15
fixed constructions (15) 15
galleries (15) 15
immunohistochemistry (15) 15
large underground chambers (15) 15
mining (15) 15
public, environmental & occupational health (15) 15
shafts (15) 15
tunnels (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
breast neoplasms - etiology (14) 14
clinical medicine (14) 14
confidence intervals (14) 14
disease-free survival (14) 14
european continental ancestry group - genetics (14) 14
genes (14) 14
genetic association studies (14) 14
genomes (14) 14
neoplasm staging (14) 14
polymorphism (14) 14
receptors, estrogen - metabolism (14) 14
single nucleotide polymorphisms (14) 14
association (13) 13
breast neoplasms - chemistry (13) 13
breast neoplasms - drug therapy (13) 13
breast neoplasms - epidemiology (13) 13
carcinoma (13) 13
epidemiology (13) 13
gene expression (13) 13
klinisk medicin (13) 13
proportional hazards models (13) 13
skin and connective tissue diseases (13) 13
age factors (12) 12
cancer and oncology (12) 12
risk assessment (12) 12
susceptibility (12) 12
cells (11) 11
disease (11) 11
gene (11) 11
genetic variation (11) 11
oncology, experimental (11) 11
physiological aspects (11) 11
studies (11) 11
analysis (10) 10
breast (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial
by Fizazi, Karim, Prof and Massard, Christophe, MD and Bono, Petri, MD and Jones, Robert, MD and Kataja, Vesa, Prof and James, Nicholas, Prof and Garcia, Jorge A, MD and Protheroe, Andrew, MD and Tammela, Teuvo L, Prof and Elliott, Tony, MD and Mattila, Leena, MD and Aspegren, John, MSc and Vuorela, Annamari, PhD and Langmuir, Peter, MD and Mustonen, Mika, PhD and ARADES Study Grp and ARADES study group
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 975 - 985
Summary Background ODM-201 is a novel androgen receptor (AR) inhibitor designed to block the growth of prostate cancer cells through high-affinity binding to... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | ENZALUTAMIDE MDV3100 | ANTIANDROGEN | ONCOLOGY | ABIRATERONE ACETATE | ANTITUMOR-ACTIVITY | CLINICAL ACTIVITY | DOCETAXEL | AXIS | Confidence Intervals | Prognosis | Humans | Middle Aged | Male | Androgen Receptor Antagonists - pharmacology | Prostatic Neoplasms, Castration-Resistant - pathology | Patient Selection | Dose-Response Relationship, Drug | Neoplasm Metastasis | Neoplasm Invasiveness - pathology | Patient Safety | Pyrazoles - pharmacology | Drug Administration Schedule | Administration, Oral | Kaplan-Meier Estimate | Survival Rate | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostate-Specific Antigen - blood | Disease-Free Survival | Maximum Tolerated Dose | Aged | Prostatic Neoplasms, Castration-Resistant - mortality | Neoplasm Staging | Prostate cancer | Care and treatment | Metastasis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Transcription factors zeb1, twist and snai1 in breast carcinoma
by Soini, Ylermi and Tuhkanen, Hanna and Sironen, Reijo and Virtanen, Ismo and Kataja, Vesa and Auvinen, Päivi and Mannermaa, Arto and Kosma, Veli-Matti
BMC Cancer, ISSN 1471-2407, 02/2011, Volume 11, Issue 1, pp. 73 - 73
Background: Epitheliomesenchymal transition (EMT) is the process where cancer cells attain fibroblastic features and are thus able to invade neighboring... 
EPITHELIAL-MESENCHYMAL TRANSITION | CELLS | HEPATOCELLULAR-CARCINOMA | METASTASIS | ONCOLOGY | DISEASE | CADHERIN REPRESSOR SNAIL | UP-REGULATION | TUMOR-GROWTH | CANCER | EXPRESSION | Immunohistochemistry | Prognosis | Stromal Cells - pathology | Epithelial-Mesenchymal Transition - physiology | Homeodomain Proteins - metabolism | Humans | Carcinoma - mortality | Breast Neoplasms - metabolism | Female | Carcinoma - pathology | Snail Family Transcription Factors | Transcription Factors - physiology | Stromal Cells - metabolism | Carcinoma - diagnosis | Nuclear Proteins - metabolism | Transcription Factors - metabolism | Breast Neoplasms - pathology | Twist-Related Protein 1 - physiology | Survival Analysis | Breast Neoplasms - mortality | Breast Neoplasms - diagnosis | Nuclear Proteins - physiology | Carcinoma - metabolism | Homeodomain Proteins - physiology | Neoplasm Staging | Twist-Related Protein 1 - metabolism | Zinc Finger E-box-Binding Homeobox 1 | Transcription factors | Physiological aspects | Development and progression | Breast cancer | Genetic aspects | Research | Oncogenes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
by Heikki Joensuu and Petri Bono and Vesa Kataja and Tuomo Alanko and Riitta Kokko and Raija Asola and Tapio Utriainen and Taina Turpeenniemi-Hujanen and Sirkku Jyrkkiö and Kari Möykkynen and Leena Helle and Seija Ingalsuo and Marjo Pajunen and Mauri Huusko and Tapio Salminen and Päivi Auvinen and Hannu Leinonen and Mika Leinonen and Jorma Isola and Pirkko-Liisa Kellokumpu-Lehtinen
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 34, pp. 5685 - 5692
Purpose Docetaxel has not been compared with vinorelbine as adjuvant treatment of early breast cancer. Efficacy and long-term safety of a short course of... 
1ST-LINE TREATMENT | WEEKLY PACLITAXEL | PHASE-II TRIAL | COMBINATIONS | EFFICACY | ONCOLOGY | SAFETY | DOXORUBICIN | FOLLOW-UP | CHEMOTHERAPY | PLUS | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Epirubicin - administration & dosage | Vinblastine - administration & dosage | Antibodies, Monoclonal, Humanized | Breast Neoplasms - chemistry | Vinblastine - analogs & derivatives | Adult | Female | Chemotherapy, Adjuvant | Neoplasm Recurrence, Local | Survival Rate | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | Receptor, ErbB-2 - analysis | Trastuzumab | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Large-scale genotyping identifies 41 new loci associated with breast cancer risk
by Michailidou, Kyriaki and Hall, Per and Gonzalez-Neira, Anna and Ghoussaini, Maya and Dennis, Joe and Milne, Roger L and Schmidt, Marjanka K and Chang-Claude, Jenny and Bojesen, Stig E and Bolla, Manjeet K and Wang, Qin and Dicks, Ed and Lee, Anew and Turnbull, Clare and Rahman, Nazneen and Fletcher, Olivia and Peto, Julian and Gibson, Lorna and dos Santos Silva, Isabel and Nevanlinna, Heli and Muranen, Taru A and Aittomäki, Kristiina and Blomqvist, Carl and Czene, Kamila and Irwanto, Astrid and Liu, Jianjun and Waisfisz, Quinten and Meijers-Heijboer, Hanne and Adank, Muriel and van der Luijt, Rob B and Hein, Rebecca and Dahmen, Norbert and Beckman, Lars and Meindl, Alfons and Schmutzler, Rita K and Müller-Myhsok, Bertram and Lichtner, Peter and Hopper, John L and Southey, Melissa C and Makalic, Enes and Schmidt, Daniel F and Uitterlinden, Ane G and Hofman, Albert and Hunter, David J and Chanock, Stephen J and Vincent, Daniel and Bacot, François and Tessier, Daniel C and Canisius, Sander and Wessels, Lodewyk F. A and Haiman, Christopher A and Shah, Mitul and Luben, Robert and Brown, Judith and Luccarini, Craig and Schoof, Nils and Humphreys, Keith and Li, Jingmei and Nordestgaard, Børge G and Nielsen, Sune F and Flyger, Henrik and Couch, Fergus J and Wang, Xianshu and Vachon, Celine and Stevens, Kristen N and Lambrechts, Diether and Moisse, Matthieu and Paridaens, Robert and Christiaens, Marie-Rose and Rudolph, Anja and Nickels, Stefan and Flesch-Janys, Dieter and Johnson, Nichola and Aitken, Zoe and Aaltonen, Kirsimari and Heikkinen, Tuomas and Broeks, Annegien and van 't Veer, Laura J and van der Schoot, C. Ellen and Guénel, Pascal and Truong, Thérèse and Laurent-Puig, Pierre and Menegaux, Florence and Marme, Frederik and Schneeweiss, Aneas and Sohn, Christof and Burwinkel, Barbara and Zamora, M. Pilar and Perez, Jose Ignacio Arias and Pita, Guillermo and Alonso, M. Rosario and Cox, Angela and Brock, Ian W and Cross, Simon S and Reed, Malcolm W. R and Sawyer, Elinor J and Tomlinson, Ian and Kerin, Michael J and Miller, Nicola and Henderson, Brian E and ... and kConFab Investigators and GENICA Gene Environm Interaction B and Hereditary Breast Ovarian Canc Res and Australian Ovarian Can Study Grp and Breast Ovarian Canc Susceptibility and Australian Ovarian Cancer Study Group and GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network and Breast and Ovarian Cancer Susceptibility Collaboration and Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) and The Breast and Ovarian Cancer Susceptibility Collaboration and The GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 4, pp. 353 - 361
Breast cancer is the most common cancer among women. Common variants at 27 loci have been identified as associated with susceptibility to breast cancer, and... 
PROSTATE | COMMON VARIANTS | ALLELES | GENE | SIGNALING PATHWAY | GENETICS & HEREDITY | SUSCEPTIBILITY LOCI | 1P11.2 | CONFER SUSCEPTIBILITY | EXPRESSION | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease | Genome-Wide Association Study | Meta-Analysis as Topic | Humans | Risk Factors | Breast Neoplasms - etiology | Genetic Loci - genetics | Cooperative Behavior | Genotype | Gene-Environment Interaction | Case-Control Studies | Polymorphism, Single Nucleotide - genetics | Female | Quantitative trait loci | BRCA mutations | Breast cancer | Genetic aspects | Research | Identification and classification | Health aspects | Risk factors | Women | Studies | Genealogy | Genetics | Genomes | Gene loci | Ovarian cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
by Michailidou, Kyriaki and Beesley, Jonathan and Lindstrom, Stephen and Canisius, Sander and Dennis, Joe and Lush, Michael and Maranian, Melanie and Bolla, Manjeet and Wang, Qing and Shah, Mitul and Perkins, Barbara and Czene, Kamila and Eriksson, Mikael and Darabi, Hatef and Brand, Judith S and Bojesen, Stig and Nordestgaard, Børge and Flyger, Henrik and Nielsen, Sune and Rahman, Nazneen and Turnbull, Clare and Fletcher, Olivia and Peto, Julian and Gibson, Lorna and Santos Silva, Isabel and Chang-Claude, Jenny and Flesch-Janys, Dieter and Rudolph, Anja and Eilber, Ursula and Behrens, Timothy and Nevanlinna, Heli and Muranen, Taru and Aittomäki, Kristiina and Blomqvist, Carl and Khan, Sofia and Aaltonen, Kirsimari and Ahsan, Habibul and Kibriya, Muhammad and Whittemore, Alice S and John, Esther M and Malone, Kathleen E and Gammon, Marilie and Santella, Regina M and Ursin, Giske and Makalic, Enes and Schmidt, Daniel and Casey, Graham and Hunter, David J and Gapstur, Susan M and Gaudet, Mia and Diver, Ryan and Haiman, Christopher A and Schumacher, Freick and Henderson, Brian and Le Marchand, Loic and Berg, Christine and Chanock, Stephen and Figueroa, Jonine and Hoover, Robert N and Lambrechts, Diether and Neven, Patrick and Wildiers, Hans and Limbergen, Erik and Schmidt, Marjanka and Broeks, Annegien and Verhoef, S and Cornelissen, Sten and Couch, Fergus and Olson, Janet and Hallberg, Boubou and Vachon, Celine and Waisfisz, Quinten and Meijers-Heijboer, Hanne and Adank, Muriel and Luijt, Rob and Li, Jingmei and Liu, Jianjun and Humphreys, Manjeet and Kang, Daehee and Choi, Ji-Yeob and Park, Sue K and Yoo, K.Y and Matsuo, Keitaro and Ito, Hidemi and Iwata, Hiroji and Tajima, Kazuo and Guénel, Pascal and Truong, Thérèse and Mulot, Claire and Sanchez, Marie and Burwinkel, Barbara and Marme, Federick and Surowy, Harald and Sohn, Christof and Wu, Anna H and Tseng, Chiu-chen and Van Den Berg, David and Stram, Daniel O and González-Neira, Anna and Benítez, Javier and ... and KConFab Investigators and AOCS Grp and BOCS and NBCS and GENICA Network and kConFab Investigators and AOCS Group and Medicinska fakulteten and Kirurgi and Institutionen för kirurgisk och perioperativ vetenskap and Umeå universitet
Nature Genetics, ISSN 1061-4036, 04/2015, Volume 47, Issue 4, pp. 373 - 380
textabstractGenome-wide association studies (GWAS) and large-scale replication studies have identified common variants in 79 loci associated with breast... 
COMMON VARIANTS | ALLELES | METAANALYSIS | GENOTYPE IMPUTATION | GENETICS & HEREDITY | ESTROGEN | CONFER SUSCEPTIBILITY | RISK | OVARIAN-CANCER | BRCA1 | CHEK2-ASTERISK-1100DELC | Genetic Predisposition to Disease | Genome-Wide Association Study | Meta-Analysis as Topic | Breast Neoplasms - genetics | Microarray Analysis | Humans | Female | Polymorphism, Single Nucleotide | Genetic Loci | Case-Control Studies | Cohort Studies | Quantitative trait loci | Genetic susceptibility | Genetic research | Breast cancer | Genetic aspects | Research | Identification and classification | Risk factors | Studies | Datasets | Genealogy | Disease | Womens health | Genes | Genomes | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer
by Loi, Sherene and Michiels, Stefan and Lambrechts, Diether and Fumagalli, Debora and Claes, Bart and Kellokumpu-Lehtinen, Pirkko-Liisa and Bono, Petri and Kataja, Vesa and Piccart, Martine J and Joensuu, Heikki and Sotiriou, Christos
Journal of the National Cancer Institute, ISSN 0027-8874, 07/2013, Volume 105, Issue 13, pp. 960 - 967
Certain somatic alterations in breast cancer can define prognosis and response to therapy. This study investigated the frequencies, prognostic effects, and... 
CELLS | PIK3CA MUTATIONS | AMPLIFICATION | ONCOLOGY | PI3K PATHWAY | DUAL PI3K/MTOR INHIBITOR | PTEN | NVP-BEZ235 | RESISTANCE | SUPPRESSION | EXPRESSION | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Gene Expression Profiling | Epirubicin - administration & dosage | Vinblastine - administration & dosage | Fluorouracil - administration & dosage | Vinblastine - analogs & derivatives | Base Sequence | Adult | Female | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Early Detection of Cancer | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Taxoids - administration & dosage | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Mutation | Neoplasm Staging | Finland - epidemiology | Trastuzumab | Breast cancer | Genetic aspects | Research | Gene mutations | Drug therapy | Patient outcomes | Monoclonal antibodies | Oncology | Womens health | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Prediction of breast cancer risk based on profiling with common genetic variants
by Mavaddat, Nasim and Pharoah, Paul and Michailidou, Kyriaki and Tyrer, Jonathan and Brook, Mark N and Bolla, Manjeet and Wang, Qing and Dennis, Joe and Dunning, Alison and Shah, Mitul and Luben, Robert and Brown, Judith and Bojesen, Stig and Nordestgaard, Børge and Nielsen, Sune F and Flyger, Henrik and Czene, Kamila and Darabi, Hatef and Eriksson, Mikael and Peto, Julian and Santos Silva, Isabel and Dudbridge, Frank and Johnson, Nichola and Schmidt, Marjanka and Broeks, Annegien and Verhoef, S and Rutgers, Emiel J and Swerdlow, Anthony and Ashworth, Alan and Orr, Nick and Schoemaker, Minouk and Figueroa, Jonine and Chanock, Stephen and Brinton, Louise and Lissowska, Jolanta and Couch, Fergus and Olson, Janet and Vachon, Celine and Pankratz, Shane and Lambrechts, Diether and Wildiers, Hans and van Ongeval, Chantal and Limbergen, Erik and Kristensen, Vessela and Grenaker Alnæs, Grethe and Nord, Silje and Borresen-Dale, Anne-Lise and Nevanlinna, Heli and Muranen, Taru and Aittomäki, Kristiina and Blomqvist, Carl and Chang-Claude, Jenny and Rudolph, Anja and Seibold, Petra and Flesch-Janys, Dieter and Fasching, Peter and Haeberle, Lothar and Ekici, Arif and Beckmann, Matthias and Burwinkel, Barbara and Marme, Federick and Schneeweiss, Aneas and Sohn, Christof and Trentham-Dietz, Amy and Newcomb, Polly and Titus, Linda and Egan, Kathleen M and Hunter, David and Lindstrom, Stephen and Tamimi, Rulla and Kraft, Peter and Rahman, Nazneen and Turnbull, Clare and Renwick, Anthony and Seal, Sheila and Li, Jingmei and Liu, Jianjun and Humphreys, Manjeet and Benítez, Javier and Zamora, Pilar and Arias Pérez, José Ignacio and Menéndez, Primitiva and Jakubowska, Anna and Lubinski, Jan and Jaworska-Bieniek, Katarzyna and Durda, Katarzyna and Bogdanova, Natalia and Antonenkova, Natalia and Dörk, Thilo and Anton-Culver, Hoda and Neuhausen, Susan and Ziogas, Argyrios and Bernstein, Leslie and Devilee, Peter and Tollenaar, Rob and Seynaeve, Caroline and Asperen, Christi and Cox, Angela and Cross, Simon and Reed, Malcolm and ...
National Cancer Institute. Journal (Print), ISSN 0027-8874, 01/2015, Volume 107, Issue 5, p. 1
textabstractBackground: Data for multiple common susceptibility alleles for breast cancer may be combined to identify women at different levels of breast... 
PROSTATE | ONCOLOGY | SUBTYPES | SUSCEPTIBILITY LOCI | PREVENTION | FAMILY-HISTORY | GENOME-WIDE ASSOCIATION | Development and progression | Breast cancer | Genetic aspects | Single nucleotide polymorphisms | Health aspects | Risk factors | Womens health | Estrogen | Preventive medicine | Medical screening | Polymorphism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
by Joensuu, Heikki and Kellokumpu-Lehtinen, Pirkko-Liisa and Bono, Petri and Alanko, Tuomo and Kataja, Vesa and Asola, Raija and Utriainen, Tapio and Kokko, Riitta and Hemminki, Akseli and Tarkkanen, Maija and Turpeenniemi-Hujanen, Taina and Jyrkkiö, Sirkku and Flander, Martti and Helle, Leena and Ingalsuo, Seija and Johansson, Kaisu and Jääskeläinen, Anna-Stina and Pajunen, Marjo and Rauhala, Mervi and Kaleva-Kerola, Jaana and Salminen, Tapio and Leinonen, Mika and Elomaa, Inkeri and Isola, Jorma and FinHer Study Investigators
The New England Journal of Medicine, ISSN 0028-4793, 02/2006, Volume 354, Issue 8, pp. 809 - 820
In this randomized comparison of adjuvant treatment with docetaxel or vinorelbine for early breast cancer, women with HER2-positive cancer were randomly... 
SURVIVAL | MEDICINE, GENERAL & INTERNAL | COMBINATIONS | ONCOGENE | AMPLIFICATION | EPIRUBICIN | CYCLOPHOSPHAMIDE | POOR-PROGNOSIS | ANTIBODY | CHEMOTHERAPY | PLUS | Breast Neoplasms - surgery | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Stroke Volume - drug effects | Vinblastine - administration & dosage | Breast Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized | Disease-Free Survival | Taxoids - administration & dosage | Analysis of Variance | Vinblastine - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Genes, erbB-2 | Vinblastine - adverse effects | Breast Neoplasms - mortality | Female | Receptor, ErbB-2 - immunology | Chemotherapy, Adjuvant | Receptor, ErbB-2 - analysis | Heart Diseases - chemically induced | Taxoids - adverse effects | Trastuzumab | Breast cancer | Dosage and administration | Drug therapy | Docetaxel | Women | Monoclonal antibodies | Comparative analysis | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
by Bojesen, Stig E and Pooley, Karen A and Johnatty, Sharon E and Beesley, Jonathan and Michailidou, Kyriaki and Tyrer, Jonathan P and Edwards, Stacey L and Pickett, Hilda A and Shen, Howard C and Smart, Chanel E and Hillman, Kristine M and Mai, Phuong L and Lawrenson, Kate and Stutz, Michael D and Lu, Yi and Karevan, Rod and Woods, Nicholas and Johnston, Rebecca L and French, Juliet D and Chen, Xiaoqing and Weischer, Maren and Nielsen, Sune F and Maranian, Melanie J and Ghoussaini, Maya and Ahmed, Shahana and Baynes, Caroline and Bolla, Manjeet K and Wang, Qin and Dennis, Joe and McGuffog, Lesley and Barrowdale, Daniel and Lee, Anew and Healey, Sue and Lush, Michael and Tessier, Daniel C and Vincent, Daniel and Bacot, Françis and Vergote, Ignace and Lambrechts, Sanina and Despierre, Evelyn and Risch, Harvey A and González-Neira, Anna and Rossing, Mary Anne and Pita, Guillermo and Doherty, Jennifer A and Alvarez, Nuria and Larson, Melissa C and Fridley, Brooke L and Schoof, Nils and Chang-Claude, Jenny and Cicek, Mine S and Peto, Julian and Kalli, Kimberly R and Broeks, Annegien and Armasu, Sebastian M and Schmidt, Marjanka K and Braaf, Linde M and Winterhoff, Boris and Nevanlinna, Heli and Konecny, Gottfried E and Lambrechts, Diether and Rogmann, Lisa and Guénel, Pascal and Teoman, Attila and Milne, Roger L and Garcia, Joaquin J and Cox, Angela and Shridhar, Vijayalakshmi and Burwinkel, Barbara and Marme, Frederik and Hein, Rebecca and Sawyer, Elinor J and Haiman, Christopher A and Wang-Gohrke, Shan and Anulis, Irene L and Moysich, Kirsten B and Hopper, John L and Odunsi, Kunle and Lindblom, Annika and Giles, Graham G and Brenner, Hermann and Simard, Jacques and Lurie, Galina and Fasching, Peter A and Carney, Michael E and Radice, Paolo and Wilkens, Lynne R and Swerdlow, Anthony and Goodman, Marc T and Brauch, Hiltrud and Garcia-Closas, Montserrat and Hillemanns, Peter and Winqvist, Robert and Dürst, Matthias and Devilee, Peter and Runnebaum, Ingo and Jakubowska, Anna and Lubinski, Jan and Mannermaa, Arto and Butzow, Ralf and ... and Gene Environm Interactimi Breast and Kathleen Cuningham Fdn Consortium and Australian Ovarian Canc Study and Epidemiological Study BRCA1 and Hereditary Breast Ovarian Canc Res and Genetic Modifiers Canc Risk BRCA1 and Australian Canc Study and Swedish Breast Canc Study SWE-BRCA and Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO) and Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) and Gene Environment Interaction and Breast Cancer (GENICA) and Swedish Breast Cancer Study (SWE-BRCA) and Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE) and Australian Ovarian Cancer Study and Australian Cancer Study and Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) and The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) and Medicinska fakulteten and Umeå universitet and Institutionen för strålningsvetenskaper
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 4, pp. 371 - 384
TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOGs, we... 
BUCCAL CELLS | GENETIC-VARIATION | COMMON VARIANTS | TERT-CLPTM1L LOCUS | REVERSE-TRANSCRIPTASE | SEQUENCE | GENETICS & HEREDITY | SUSCEPTIBILITY LOCI | POLYMORPHISM | FIBROBLASTS | GENOME-WIDE ASSOCIATION | Luciferases - metabolism | Alternative Splicing | Oligonucleotide Array Sequence Analysis | Humans | Breast Neoplasms - etiology | Genetic Loci - genetics | Ovarian Neoplasms - pathology | Gene Expression Profiling | Case-Control Studies | DNA Methylation | Telomerase - genetics | Female | Ovarian Neoplasms - etiology |